login
register
Home
Getting Started
ChartMill Overview
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
USA Market Overview
Canada Market Overview
Europe Market Overview
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Swing Trading Course
Account
Disclaimer
Affiliate
Contact
Privacy
ARENA PHARMACEUTICALS INC (ARNA) Stock News
USA
- NASDAQ:ARNA -
Common Stock
99.99
+0.06 (+0.06%)
Last: 3/10/2022, 8:10:48 PM
99.99
0 (0%)
After Hours:
3/10/2022, 8:10:48 PM
Overview
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News
ARNA Latest News, Press Relases and Analysis
All
Press Releases
4 years ago - By: Benzinga
Arena Pharmaceuticals Inc. Climbs To Annual-High Share Price
4 years ago - By: InvestorPlace
- Mentions:
BMY
AMLX
AKBA
ASND
...
7 Biotech Stocks With Key Catalysts in March
4 years ago - By: Benzinga
- Mentions:
MXC
NINE
INLB
NEPT
...
Bullish Tuesday For Marijuana Stocks - Nine Energy Service, ReneSola Among Top Gainers
4 years ago - By: Arena Pharmaceuticals, Inc.
Arena Reports Fourth Quarter and Full Year 2021 Financial Results and Key Program Updates
4 years ago - By: Arena Pharmaceuticals, Inc.
Arena Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
4 years ago - By: Arena Pharmaceuticals, Inc.
Arena Pharmaceuticals to Release Fourth Quarter and Full-Year 2021 Financial Results and Provide Corporate Update on February 23
4 years ago - By: Arena Pharmaceuticals, Inc.
Arena Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
4 years ago - By: InvestorPlace
- Mentions:
TSLA
NVDA
AAPL
MARA
...
7 Long-Term Stocks to Buy and Hold Until 2030
4 years ago - By: Arena Pharmaceuticals, Inc.
Arena Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Please enable JavaScript to continue using this application.